50 related articles for article (PubMed ID: 14578141)
1. The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.
Palma MD; Domchek SM; Stopfer J; Erlichman J; Siegfried JD; Tigges-Cardwell J; Mason BA; Rebbeck TR; Nathanson KL
Cancer Res; 2008 Sep; 68(17):7006-14. PubMed ID: 18703817
[TBL] [Abstract][Full Text] [Related]
2. A genome wide linkage search for breast cancer susceptibility genes.
Smith P; McGuffog L; Easton DF; Mann GJ; Pupo GM; Newman B; Chenevix-Trench G; ; Szabo C; Southey M; Renard H; Odefrey F; Lynch H; Stoppa-Lyonnet D; Couch F; Hopper JL; Giles GG; McCredie MR; Buys S; Andrulis I; Senie R; ; Goldgar DE; Oldenburg R; Kroeze-Jansema K; Kraan J; Meijers-Heijboer H; Klijn JG; van Asperen C; van Leeuwen I; Vasen HF; Cornelisse CJ; Devilee P; Baskcomb L; Seal S; Barfoot R; Mangion J; Hall A; Edkins S; Rapley E; Wooster R; Chang-Claude J; Eccles D; Evans DG; Futreal P; Nathanson KL; Weber BL; ; Rahman N; Stratton MR
Genes Chromosomes Cancer; 2006 Jul; 45(7):646-55. PubMed ID: 16575876
[TBL] [Abstract][Full Text] [Related]
3. Familial segregation of venous thromboembolism.
Heit JA; Phelps MA; Ward SA; Slusser JP; Petterson TM; De Andrade M
J Thromb Haemost; 2004 May; 2(5):731-6. PubMed ID: 15099278
[TBL] [Abstract][Full Text] [Related]
4. Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China.
Zhang W; Bailey-Wilson JE; Li W; Wang X; Zhang C; Mao X; Liu Z; Zhou C; Wu M
Am J Hum Genet; 2000 Jul; 67(1):110-9. PubMed ID: 10841811
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China.
Guohong Z; Min S; Duenmei W; Songnian H; Min L; Jinsong L; Hongbin L; Feng Z; Dongping T; Heling Y; Zhicai L; Shiyong L; Quansheng G; Xiaoyun L; Yuxia G
PLoS One; 2010 Mar; 5(3):e9668. PubMed ID: 20300624
[TBL] [Abstract][Full Text] [Related]
6. Frailty Models for Familial Risk with Application to Breast Cancer.
Gorfine M; Hsu L; Parmigiani G
J Am Stat Assoc; 2013 Dec; 108(504):1205-1215. PubMed ID: 24678132
[TBL] [Abstract][Full Text] [Related]
7. Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction.
Li S; MacInnis RJ; Lee A; Nguyen-Dumont T; Dorling L; Carvalho S; Dite GS; Shah M; Luccarini C; Wang Q; Milne RL; Jenkins MA; Giles GG; Dunning AM; Pharoah PDP; Southey MC; Easton DF; Hopper JL; Antoniou AC
Am J Hum Genet; 2022 Oct; 109(10):1777-1788. PubMed ID: 36206742
[TBL] [Abstract][Full Text] [Related]
8. Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer.
Hilbers FS; van 't Hof PJ; Meijers CM; Mei H; Michailidou K; Dennis J; Hogervorst FBL; Nederlof PM; van Asperen CJ; Devilee P
Int J Cancer; 2020 Nov; 147(10):2708-2716. PubMed ID: 32383162
[TBL] [Abstract][Full Text] [Related]
9. Complex Segregation Analysis Provides Evidence for Autosomal Dominant Transmission in the Chinese Han Families with Ankylosing Spondylitis.
Jiang Y; Lv Q; Rao S; Liao Z; Zhang P; Yang M; Li Q; Cao S; Lin Z; Gu J
Biomed Res Int; 2017; 2017():4515701. PubMed ID: 29349072
[TBL] [Abstract][Full Text] [Related]
10. Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.
Vos JR; Hsu L; Brohet RM; Mourits MJ; de Vries J; Malone KE; Oosterwijk JC; de Bock GH
J Clin Oncol; 2015 Aug; 33(23):2553-62. PubMed ID: 26150446
[TBL] [Abstract][Full Text] [Related]
11. Can a phenotype for recessive inheritance in breast cancer be defined?
Ellberg C; Jönsson G; Olsson H
Fam Cancer; 2010 Dec; 9(4):525-30. PubMed ID: 20549370
[TBL] [Abstract][Full Text] [Related]
12. Familial breast and bowel cancer: does it exist?
Scott RJ; Ashton KA
Hered Cancer Clin Pract; 2004 Feb; 2(1):25-9. PubMed ID: 20233481
[TBL] [Abstract][Full Text] [Related]
13. Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance.
Tayo BO; DiCioccio RA; Liang Y; Trevisan M; Cooper RS; Lele S; Sucheston L; Piver SM; Odunsi K
PLoS One; 2009 Jun; 4(6):e5939. PubMed ID: 19536330
[TBL] [Abstract][Full Text] [Related]
14. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
Kaufman DJ; Beaty TH; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
16. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
17. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
[TBL] [Abstract][Full Text] [Related]
18. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
Bonadona V; Lasset C
Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
